[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2017 Winning Strategies in Molecular Diagnostics: Integrating New Technology Planning with Business and Corporate Strategies--Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence

March 2017 | 1050 pages | ID: 2C463BAFF9AEN
Venture Planning Group

US$ 22,050.00 US$ 24,500.00 -10 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This new seven-country study from VPGMarketResearchcontains 1,050 pages, 96 tables, and is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years.

Highlights

Business and technological trends in seven major markets: France, Germany, Italy, Japan, Spain, UK, and US- Five-year test volume and sales forecasts- Market shares of leading competitors- Feature comparison of major analyzers- Profiles of market players and start-up firms developing innovative technologiesand products- Specific product and business opportunities for instrument and consumable suppliers.

Rationale

The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Geographic Coverage

France- Germany- Italy- Japan- Spain- UK- USA

Worldwide Market Overview

Laboratories performing DNA sequencing and molecular diagnostic testingby country and market segment.- Five-year test volume and sales projections by country.

Market Segmentation Analysis

Sales and market shares of major suppliers of molecular diagnosticreagent kits and components.- Five-year test volume and sales forecasts for major applications, including:- Infectious Diseases- Forensic Testing- Cancer- Paternity Testing/HLA Typing- Genetic Diseases- Others- Five-year test volume and sales projections for over 30 NAT assays.- A comprehensive analysis of the sequencing market, by country and laboratory segment,including:- Industrial- Academic- Government- Commercial- Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers, by country.

Product/Technology Review

Comparison of leading molecular diagnosticanalyzers from Abbott, Beckman Coulter, BD,Bio-Rad,Gen-Probe, Roche, Tecan and other suppliers.- Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods, including:- PCR- bDNA- SDA- NASBA- TMA- SSSR, and others- LCR- Worldwide listings of companies, universities and research centers developing new molecular- diagnostictechnologies and products.

Competitive Assessments

Extensive strategic assessments of major suppliers and emerging market entrants,including their sales, product portfolios, marketing tactics, collaborative arrangements andnew technologies/products in R&D.- Comprehensive listings of companies developing and marketing molecular diagnostics products, by test and application.

Opportunities and Strategic Recommendations

Specific new product development opportunities with potentially significant market appeal during the next five years.- Design criteria for new products.- Alternative market penetration strategies.- Potential market entry barriers and risks.- Business planning issues and concerns.

Methodology

This report is based on a combination of primary and secondary information sources, including interviews with laboratory directors and executives of leading diagnostic companies and start-up firms developing innovative technologies and products in the U.S., five major European countries and Japan. In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as VPGMarketResearchs proprietary data base was conducted.Contains 1,050 pages and 96 tables
INTRODUCTION

WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. DNA Sequencing
  1. Introduction
  2. Sequencing Methods
  3. Autoradiography
  4. The Human Genome Project
  5. Sequencing Automation
  6. Image Scanners
  7. Fluorescent Detection
  8. Gene Profiling
  9. Gene Expression
  10. Polymorphism Screening
  11. Protein Interaction Networks
B. DNA And RNA Probe Technology
  1. Basic Principles
  2. Probe Preparation
  3. The DNA Probe Test
    a. Sample Preparation
    b. Hybridization
    c. Separation
    d. Detection/Measurement
  4. Test Formats
    a. Filter Hybridization
    b. Southern Blot
    c. Northern Blot
    d. In Situ Hybridization
    e. Others
  5. Labeling Techniques
  6. Amplification Methods
    Polymerase Chain Reaction
      Temperature Cyclers
      PCR Variations
        Immuno-PCR
        QC-PCR
        DAP-PCR
    Strand Displacement Activation
    TMA
    Ligase Chain Reaction
    Branched DNA
      Hybridization Protection Assay
    Nucleic-Acid Sequence-Based Amplification
    Self-Sustained Sequence Replicase
    Others
      Ampliprobe
      CAR
      CAS
      CPT
      Dendritic Polymer Technology
      ISO-CR
      LAT
      Probe Networks
      RAMP
      Repair Chain Reaction
      Rolling Circles
      Sequence Independent Gene Amplification
      Sequence Initiation Reaction
      SISPA
      Solid Phase Amplification
C. Detection Technologies
  1. Radioactive Methods
    a. Overview
    b. Major Isotopes
      P-32
      S-35
      H-3
      I-125
  2. Non-Isotopic Methods
    a. Enzymatic Labels
    b. Chemical Labeling
      Indirect Chemical Labeling
      Direct Chemical Labeling
    c. Fluorescence
    d. Chemiluminescence
    e. Electrical Conductivity
D. Instrumentation Review
  1. Abbott LCx
  2. Beckman Coulter/Biomek FK
  3. Becton Dickinson SDA
  4. Bio-Rad GeneScope
  5. Gen-Probe Tigris
  6. Roche Cobas Amplicor
  7. Tecan LS Series
E. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip
  Liquid Transportation and Mixing
  Separation
  Reaction
  Detection
F. Pharmacogenomics
G. Major Applications
  1. Microbiology/Infectious Diseases
    a. Overview
    b. Major Infectious Diseases
      AIDS
        Structure and Composition
        Classification
        AIDS Origins
        Animal Lentivirus Systems
        Virus Receptors
        HIV Infections in Humans
          Pathogenesis and Pathology
        CD4T Lymphocytes and Memory Cells
        Monocytes and Macrophages
        Lymphoid Organs
        Neural Cells
        Viral Coinfections
          Clinical Findings
        Plasma Viral Load
        Pediatric AIDS
          Neurologic Disease
          Opportunistic Infections
          Cancer
        Immunity
          Virus Isolation
          Serology
          Viral Nucleic Acid/Antigen Detection
        Epidemiology
          Worldwide Spread of AIDS
          United States
          Routes of Transmission
        DNA Probes
          Overview
          Quantitative PCR
          In Situ PCR
          Needed Improvements
        Viral Load/Drug Resistance Testing
        Genotype and Phenotype Testing
        Blood Banking Considerations
      Adenovirus
        Background
        Diagnostic Tests
        Vaccines and Drugs
        Adeno-Associated Viruses (AAV)
      Anthrax/Bacillus Anthracis
        Background
        Diagnostic Tests
        Vaccines and Drugs
      Babesiosis
        Background
      BEA and Other Bartonella Diseases
        Background
        Diagnostic Tests
        Vaccines and Drugs
      Chagas Disease
        Background
      Campylobacter
        Background
        Diagnostic Tests
          Culture Identification
        Vaccines and Drugs
      Chlamydia
        Background
          Chlamydia psittaci
          Chlmaydia pneumoniae
          Chlamydia trachomatis
        Diagnostic Tests
        Vaccines and Drugs
      Creutzfeldt-Jakob’s Disease
        Background
        Blood Transmission
        Diagnostic Tests
        Major Commercial and Academic Players
          Bayer
          Disease Sciences/Bio Tec Global
          Imperial College School of Medicine
          Ortho-Clinical Diagnostics
          Pall
          ProMetic Life Sciences
          Proteome Sciences/Idexx
          Q-One Biotech
          Serono
          U.S. Agricultural Research Service
        Drugs
        Vaccines
      Cytomegalovirus
        Background
          Chorioretinitis
          Gastrointestinal
          Central Nervous System Disease
        Diagnostic Tests
        Vaccines and Drugs
      Ebola Virus
        Background
          Epidemiology
          Clinical Syndromes
        Diagnostic Tests
        Vaccines and Drugs
      EchoVirus
        Background
          Acute Aseptic Meningitisis
          Encephalitis
          Exanthems
          Respiratory Disease
          Myopericarditis
          Neonatal Infections
        Diagnostic Tests
        Vaccines and Drugs
      Encephalitis
        Background
        Diagnostic Tests
        Vaccines and Drugs
      Enteroviruses
        Background
        Diagnostic Tests
          Viral Isolation and Identification
          Antibody Tests
        Vaccines and Drugs
      Epstein-Barr Virus
        Background
        Diagnostic Tests
        Vaccines and Drugs
      Gonorrhea
        Background
        Diagnostic Tests
        Vaccines and Drugs
      Hepatitis
        Hepatitis A
        Hepatitis B
          Structure and Composition
          Replication
        Hepatitis C
        Hepatitis D (Delta)
        Hepatitis E
        Hepatitis G
        Hepatitis Infections Pathology
        Clinical Findings
        Laboratory Tests
          Hepatitis A
          Hepatitis B
          Hepatitis C
          Hepatitis D
          Hepatitis E
        Virus-Host Immune Reactions
        Epidemiology
          Hepatitis A
          Hepatitis B
          Hepatitis C
          Hepatitis D (Delta)
        Vaccines and Drugs
      Herpes Simplex Virus
        Background
        Diagnostic Tests
        Vaccines and Drugs
      Legionella
        Background
        Diagnostic Tests
        Vaccines and Drugs
      Lyme Disease
        Background
          Clinical Description
          Clinical Case Definition
          Laboratory Criteria for Diagnosis
          Case Classification
        Diagnostic Tests
        Vaccines and Drugs
      Malaria
      Mycoplasma
        Background
          Ureaplasma Urealyticum & Mycoplasma Hominis
        Diagnostic Tests
        Vaccines and Drugs
      Papillomaviruses/HPV
        Background
          HPV in Cancer
          Cervical Neoplasm
        Diagnostic Tests
        Vaccines and Drugs
          Prevention
      Parvovirus B19
        Background
          Microbiology
          Epidemiology
          Clinical Syndromes
          Erythema Infectiosum (Slapped Cheek)
          Adult Polyarthropathy
          Transient Aplastic Crisis
          Transient Pancytopenia
          Red Cell Aplasia in Immunocompromised
          Perinatal Infections
        Diagnostic Test
        Vaccines and Drugs
      Pneumonia
        Background
        Diagnostic Tests
        Vaccines and Drugs
      Polyomaviruses
        Background
        Diagnostic Tests
        Vaccines and Drugs
      Salmonellosis
        Background
        Diagnostic Tests
        Vaccines and Drugs
      Shigellosis
        Background
        Diagnostic Tests
        Vaccines and Drugs
      Streptococci
        Background
        Diagnostic Tests
        Vaccines and Drugs
          Group A Streptococci
          Group B Streptococci
      Toxoplasmosis
        Background
        Diagnostic Tests
        Vaccines and Drugs
      Tuberculosis
        Background
        Diagnostic Tests
          Microscopic Characteristics
          Cultural Characteristics
          Skin Tests
          MDRTB
        Vaccines and Drugs
      West Nile Virus
        Background
          Clinical Syndromes
        Diagnostic Tests
        Vaccines and Drugs
      Yersinia
        Background
        Diagnostic Tests
        Vaccines and Drugs
    c. Antibiotic Susceptibility
  2. Cancer Testing
    a. Overview
    b. Major Cancer Types
      Prostate
      Lung
      Colon and Rectum
      Breast
      Skin
      Uterine
      Leukemia
      Oral
    c. Oncogenes
      Abl/abl-bcr
      AIB1
      BCL-2
      BRCA1
      CD44
      C-fos
      C-myb
      C-myc
      CYP17
      Erb-B
      HPC1
      N-myc
      P40
      P51
      P53
      PIK3CA
      PTI-1
      Ras
      Reg
      Sis
      Src
  3. Genetic Diseases
    a. Overview
    b. Nucleic Acid Amplification
    c. Chromosome Imaging
    d. Genomics Technologies
    e. Proteomics Technologies
    f. Current Pharmacogenomic Tests
    g. Future Pharmacogenomic Testing
    h. Major Diseases
      Achondroplasia
      Autosomal Dominant Polycystic Kidney Disease
      Cancer
      Cosmetogenomics
      Cystic Fibrosis
      Down's Syndrome
      Duchenne and Becker Muscular Dystrophy
      Factor V (Leiden)
      Factor IX Deficiency
      Fragile X Syndrome
      Heart Disease
      Hemochomatosis
      Hemophilia
      Huntington's Disease
      Maternal-Fetal Incompatibility
      Multiple Endocrine Neoplasia
      Phenylketonuria (PKU)
      Polycystic Kidney Disease (PKD)
      Prenatal Screening
      Retinitis Pigmentosa
      Retinoblastoma
      Sickle Cell Anemia
      Spinal Muscular Atrophy
      Vitamin B12 Metabolism
    i. Social Issues and Concerns
  4. Forensic Testing
    a. Overview
    b. Multilocus and Single Locus Probes
      Multilocus Probes
      Single Locus Probes
      PCR and RFLP
    c. The FBI
    d. DNA Profile Data Banks
      U.S.A.
      U.K.
    e. Judicial Implementation
    f. Major Crime Categories
    g. Factors Contributing to the DNA Probe Market Expansion
      Technology Availability
      Use of Hair as Evidence
    h. Wildlife Forensics
  5. Paternity Testing/HLA Typing
  6. Other Applications
    a. Disease Susceptibility Testing
    b. Cardiovascular Diseases
    c. Diabetes
    d. Alzheimer's Disease
    e. Periodontal Disease
    f. Plasma Purification
    g. Organ Transplantation
    h. Water Contamination
    i. Other
H. Competing/complementing Technologies
  1. Monoclonal Antibodies/Immunoassays
  2. RNA Probes
  3. Two-Dimensional Electrophoresis
  4. Flow Cytometry
I. Worldwide Market Overview
  1. Business Environment
  2. Market Structure
  3. Market Size and Growth

FRANCE

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth And Major Suppliers’ Sales And Market Shares

GERMANY

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth And Major Suppliers’ Sales And Market Shares

ITALY

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth And Major Suppliers’ Sales And Market Shares

JAPAN

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth And Major Suppliers’ Sales And Market Shares

SPAIN

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth And Major Suppliers’ Sales And Market Shares

U.K.

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth And Major Suppliers’ Sales And Market Shares

U.S.A.

A. Executive Summary
B. Business Environment
  1. Health Care Expenditures
  2. Cost Consciousness
  3. Reimbursement
  4. Industry Consolidation
  5. Managed Care
    a. PPO
    b. HMO
  6. Hospitals
  7. Admissions
  8. Length of Stay
  9. Industry Diversification
  10. Physician Demographics
  11. Population Aging
    a. Chronic Illness
    b. Disease Incidence
    c. Susceptibility to Iatrogenesis
    d. Multiple Illness Cases
  12. Laboratory Regulations
  13. FDA Reform
C. Market Structure
  1. Hospitals
  2. Commercial/Private Laboratories
  3. Blood Banks
D. Market Size, Growth and Major Suppliers’ Sales and Market Shares

MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Computers, Software and Automation
D. Auxiliary Products

DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies For Decentralized Testing
Markets
  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types Of Distributors
  7. Market Segmentation

POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge And Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

COMPETITIVE PROFILES

Abbott
Affymetrix
Agilent
Applied Gene Technologies
Arca3KDUPD
Beckman Coulter/Danaher
Becton Dickinson
Biokit
BioMerieux
Bio-Rad
Biotest
Cepheid
CellMark Forenciscs/LabCorp
Decode Genetics
Diadexus
Eiken
Elitech Group
Enzo
Exact Sciences
Fujirebio
Grifols
Hologic/Gen-Probe
Illumina
Kreatech/Leica
Li-Cor Biosciences
Monogram Biosciences
Myriad Genetics
Ortho-Clinical Diagnostics
Perkin Elmer/Caliper
Proteome Sciences
Qiagen
Roche
Scienion
Sequenom
Shimadzu
Siemens
Sierra Molecular
Takara Bio
Tecan Group
Thermo Fisher

APPENDIXES

Appendix I: Major Universities and Research Centers Developing Molecular Diagnostic Technology
Appendix II: Glossary of Terms
Appendix III: Currency Exchange Rates

LIST OF TABLES

Major Companies Developing or Marketing AIDS Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Adenovirus Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Campylobacter Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Chlamydia Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing CMV Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing EBV Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Gonorrhea Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Hepatitis Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Herpes Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Legionella Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Lyme Disease Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Mycoplasma Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Papilloma Virus Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Pneumonia Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Salmonella Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Shigella Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Streptococci Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Toxoplasmosis Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Tuberculosis Molecular Diagnostic And Other Direct Identification Tests
Oncogenes Potential Application in Cancer Diagnosis
Major Companies Developing or Marketing Cancer Molecular Diagnostic Tests
Major Companies Developing or Marketing Molecular Diagnostic Test For Genetic Diseases
Worldwide, Laboratories Performing DNA Sequencing By Country
Worldwide, Molecular Diagnostics Market Potential Laboratory Universe by Country
Worldwide, Molecular Diagnostic Test Volume Forecast By Country
Worldwide, Molecular Diagnostics Market Forecast by Country
Summary Table France, Molecular Diagnostic Test Volume And Sales Forecast by Major Application
France, Laboratories Performing DNA Sequencing By Market Segment
France, Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
France, Molecular Diagnostic Test Volume Forecast By Major Application
France, Major Infectious Disease Molecular Diagnostics Test Volume Forecast
France, Infectious Disease Screening NAT Volume Forecast
France, Molecular Diagnostics Market Forecast By Major Application
France, Infectious Disease Screening NAT Reagent Market Forecast by Test
France, Molecular Diagnostics Market By Major Supplier
France, HIV/Hepatitis NAT Market Reagent Sales By Major Supplier
Summary Table Germany, Molecular Diagnostics Test Volume And Sales Forecast by Major Application
Germany, Laboratories Performing DNA Sequencing by Market Segment
Germany, Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Germany, Molecular Diagnostics Test Volume Forecast By Major Application
Germany, Major Infectious Disease Molecular Diagnostics Test Volume Forecast
Germany, Infectious Disease Screening NAT Volume Forecast
Germany, Molecular Diagnostics Market Forecast By Major Application
Germany, Infectious Disease Screening NAT Reagent Market Forecast by Test
Germany, Molecular Diagnostics Market by Major Supplier
Germany, HIV/Hepatitis NAT Market Reagent Sales by Major Supplier
Summary Table Italy, Molecular Diagnostics Test Volume And Sales Forecast by Major Application
Italy, Laboratories Performing DNA Sequencing by Market Segment
Italy, Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Italy, Molecular Diagnostics Test Volume Forecast By Major Application
Italy, Major Infectious Disease Molecular Diagnostics Test Volume Forecast
Italy, Infectious Disease Screening NAT Volume Forecast
Italy, Molecular Diagnostics Market Forecast By Major Application
Italy, Infectious Disease Screening Nat Reagent Market Forecast by Test
Italy, Molecular Diagnostics Market By Major Supplier
Italy, HIV/Hepatitis NAT Market By Major Supplier
Summary Table Japan, Molecular Diagnostics Test Volume And Sales Forecast by Major Application
Japan, Laboratories Performing DNA Sequencing by Market Segment
Japan, Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Japan, Molecular Diagnostics Test Volume Forecast By Major Application
Japan, Major Infectious Disease Molecular Diagnostics Test Volume Forecast
Japan, Infectious Disease Screening NAT Volume Forecast
Japan, Molecular Diagnostics Market Forecast By Major Application
Japan, Infectious Disease Screening Nat Reagent Market Forecast by Test
Japan, Molecular Diagnostics Market By Major Supplier
Japan, HIV/Hepatitis NAT Market Reagent Sales by Major Supplier
Summary Table Spain, Molecular Diagnostics Test Volume And Sales Forecast by Major Application
Spain, Laboratories Performing DNA Sequencing by Market Segment
Spain, Molecular Diagnostics Market, Potential Laboratory Universe by Market Segment
Spain, Molecular Diagnostics Test Volume Forecast by Major Application
Spain, Major Infectious Disease Molecular Diagnostics Test Volume Forecast
Spain, Infectious Disease Screening NAT Volume Forecast
Spain, Molecular Diagnostics Market Forecast By Major Application
Spain, Infectious Disease Screening Nat Reagent Market Forecast by Test
Spain, Molecular Diagnostics Market By Major Supplier
Spain, HIV/Hepatitis NAT Market Reagent Sales by Major Supplier
Summary Table U.K., Molecular Diagnostics Test Volume And Sales Forecast by Major Application
U.K., Laboratories Performing Dna Sequencing by Market Segment
U.K., Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
U.K., Molecular Diagnostics Test Volume Forecast By Major Application
U.K., Major Infectious Disease Molecular Diagnostics Test Volume Forecast
U.K., Infectious Disease Screening NAT Volume Forecast
U.K., Molecular Diagnostics Market Forecast By Major Application
U.K., Infectious Disease Screening NAT Reagent Market Forecast by Test
U.K., Molecular Diagnostics Market by Major Supplier
Summary Table U.S.A., Molecular Diagnostics Test Volume And Sales Forecast by Major Application
U.S.A., Laboratories Performing DNA Sequencing by Market Segment
U.S.A., Molecular Diagnostics Market, Potential Laboratory Universe by Market Segment
U.S.A., Molecular Diagnostics Test Volume Forecast By Major Application
U.S.A., Major Infectious Disease Molecular Diagnostics Test Volume Forecast
U.S.A., Infectious Disease Screening NAT Volume by Test Forecast
U.S.A., Molecular Diagnostics Market Forecast By Major Application
U.S.A., Infectious Disease Screening Nat Reagent Market Forecast by Test
U.S.A., Molecular Diagnostics Market by Major Supplier
U.S.A., HIV/Hepatitis C NAT Market Reagent Sales By Major Supplier
U.S.A., West Nile Virus NAT Market Reagent Sales By Major Supplier


More Publications